On May 18, 2016, the Wall Street Journal reported that Theranos had voided two years of lab test results based on its Edison device. WSJ here. Open access story at Ars Technica, here.
Regarding the latest news, biotech journalist Matthew Herper writes at Forbes, "Theranos isn’t very good at running a diagnostic testing business."
"For a library of links on Theranos, here.